Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fondazione del Piemonte per l'Oncologia
Stanford University
National Cancer Institute (NCI)
Palo Alto Veterans Institute for Research
AstraZeneca
Jonsson Comprehensive Cancer Center
Intima Bioscience, Inc.
Karl Landsteiner University of Health Sciences
Ohio State University Comprehensive Cancer Center
Tizona Therapeutics, Inc
Institut Bergonié
Tribhuvan University, Nepal
Second Life Therapeutics
M.D. Anderson Cancer Center
Pfizer
Lantern Pharma Inc.
Tango Therapeutics, Inc.
Alaunos Therapeutics
Jonsson Comprehensive Cancer Center
NRG Oncology
Turning Point Therapeutics, Inc.
Pfizer
BerGenBio ASA
Stony Brook University
Shanghai Pulmonary Hospital, Shanghai, China
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Hacettepe University
SWOG Cancer Research Network
University of Pennsylvania
Emory University
Novartis
Celltrion
Guangdong Association of Clinical Trials
National Taiwan University Hospital
Novartis
Janssen Research & Development, LLC
Azienda USL Reggio Emilia - IRCCS
Novartis
Yuhan Corporation
Imugene Limited
University of Rochester
Fudan University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Sun Yat-sen University
Surrey Thoracic Surgery Group